Login / Signup

RE: Chemopreventive Agents to Reduce Mammographic Breast Density in Premenopausal Women: A Systematic Review of Clinical Trials.

John L HopperTuong Linh NguyenSherly X Li
Published in: JNCI cancer spectrum (2021)
Keyphrases
  • breast cancer risk
  • clinical trial
  • polycystic ovary syndrome
  • postmenopausal women
  • phase ii
  • open label
  • cervical cancer screening
  • metabolic syndrome
  • phase iii
  • double blind
  • pregnant women